leisure time -WSS

leisure time

author：leisure time 2025-10-01 05:23:51 - browse：84

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

Biotech startup ReNAgade Therapeutics is cutting staff just seven months after raising the largest Series A round in the industry this year.

ReNAgade launched in May with hopes of becoming a one-stop shop for medicines targeting RNA, the genetic blueprints that cells use to make proteins instrumental in numerous diseases. These types of medicines are in high demand following the advent of mRNA vaccines for Covid and RNA-silencing therapies made by companies like Alnylam Pharmaceuticals.

ReNAgade was able to capitalize on that excitement when it raised a $300 million Series A round led by MPM Capital’s BioImpact Capital and F2 Ventures. But in recent days, the company decided to lay off around 10% of its 100-person team, according to a company statement and former employees’ posts on social media.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Rock icon Freddie Mercury pre

WSS

Head of FDA's diagnostics center, who led through Covid, retires

To bolster infectious disease surveillance, genomics powerhouses team up

Jailed Russian opposition leader Alexey Navalny gets 19 more years in prison

New company forms to vet health AI models, root out weaknesses

Jesse Tyler Ferguson makes friendship bracelets for Taylor Swift's Eras Tour

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

focus

leisure time

entertainment

Malaria cases in Florida and Texas: Here’s what you need to know

US Marines prepare to be put on commercial ships to deter Iranian harassment in Strait of Hormuz

Dobbs anniversary: the lost opportunity of abortion as health care

FDA sets aggressive timeline for overhauling inspection procedures

How one medical school became remarkably diverse

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

Activists slam private health insurers over coverage restrictions

Printout prescription drug information shouldn’t go digital

Activists slam private health insurers over coverage restrictions

Head of FDA's diagnostics center, who led through Covid, retires

focus

Dana Farber says 6 studies to be retracted and 31 corrected

Teen charged with murder as hate crime in killing of NYC dancer O'Shae Sibley: Sources

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

Inaction leaves children at risk from dangerous chemotherapy drug

Inaction leaves children at risk from dangerous chemotherapy drug

Jailed Russian opposition leader Alexey Navalny gets 19 more years in prison

knowledge

explore

leisure time

leisure time